The HPV vaccine works—but only if we keep trusting it
Human papillomavirus (HPV) vaccination is already saving lives in the UK—and the scale of that success is striking.
Jun 27, 2026
0
8
MeSH tree: D20.215
Human papillomavirus (HPV) vaccination is already saving lives in the UK—and the scale of that success is striking.
Jun 27, 2026
0
8
France on Wednesday announced the first confirmed case of Ebola identified on its territory: a doctor who had flown back from the Democratic Republic of Congo, which is fighting a major outbreak.
Jun 24, 2026
0
4
Managing a medical supply chain in low- and middle-income countries can mean navigating a landscape prone to extreme and unexpected disruptions. In Sierra Leone, for instance, external forces ranging from an attempted military ...
Jun 23, 2026
0
6
When vaccination rates drop—as is the case with adult influenza vaccinations in Canada and child measles vaccinations in British Columbia—the explanation is often that people are "hesitant."
Jun 19, 2026
0
7
A new study from RCSI University of Medicine and Health Sciences demonstrates a novel approach in anticancer vaccine development. The results, published in Molecular Therapy Oncology, present the first preclinical evidence ...
Jun 18, 2026
0
31
High-income countries that initiated widespread administration of the human papillomavirus (HPV) vaccine in the mid-2000s have experienced substantial declines in cervical cancer cases, marking a significant achievement in ...
Jun 18, 2026
0
20
The HPV vaccine for cervical cancer has reduced the risk of dying from the disease before age 30 in England to almost zero, the first study of its kind showed Thursday.
Jun 18, 2026
0
10
A fast-rising strep bacterium has become increasingly notorious for causing serious infections in humans, including complications that can lead to muscle damage and patient death. New Houston Methodist research published ...
Jun 17, 2026
0
4
Infant mortality in the U.S. dropped to a new all-time low in 2025, according to preliminary government data.
Jun 16, 2026
0
3
Anti-T-lymphocyte globulin (ATLG) for the prevention of graft-versus-host disease (GvHD) reduces complications and infection-related mortality compared with post-transplant cyclophosphamide (PTCy) in allogeneic hematopoietic ...
Jun 15, 2026
0
3